Covid-19 roundup: Can­cer drug re­search takes a big hit, sur­vey finds; Chaot­ic remde­sivir dis­tri­b­u­tion con­tin­ues to anger doc­tors

Emerg­ing da­ta sug­gest that the Covid-19 pan­dem­ic has led to the sus­pen­sion of over 1,000 tri­als glob­al­ly — and it looks like can­cer re­search in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.